Latest Genzyme Stories
Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and treatment MONTREAL, Sept.
-- 2Q Revenue Increased 71%, Compared to Prior Year -- SOUTH SAN FRANCISCO, Calif., Aug.
PARIS, July 31, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014.
STOCKHOLM, July 3, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, is very pleased to announce that Mrs Ann-Tove Kongsnes,
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Neuralstem, Inc.
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated